previous compound ID: 143 next compound
InChIKey: AKNNEGZIBPJZJG-MSOLQXFVSA-N
SMILES: CN1CCC2=CC3=C(C(=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "SD Macknight" "D Rotin" "J Goepp" "R Robert" "E Matthes" "DY Thomas" "GW Carlile" "JW Hanrahan" "B Kus"

chemical graph of compound 143





CID is 275196
synonyms found at PubChem are:
noscapine, Tusscapine, Terbenol, Capval, 128-62-1, Coscopin, Narcompren, Narcosine, Vadebex, Methoxyhydrastine, Narcotin, Noscapalin, Noscapin, Opianine, Opianin, NARCOTINE, Narcotussin, Longatin, Narkotin, Nectadon, Nicolane, Nipaxon, Lyobex, Opian, O-Methylnarcotoline, (-)-Narcotine, Coscotabs, alpha-Narcotine, Key-tusscapine, Noscapal, Noscapina, Noscapinum, Hederix (free base), L-alpha-Narcotine, (-)-alpha-narcotine, Noscopine, UNII-8V32U4AOQU, NSC 5366, .alpha.-Narcotine, Gnoscopine, Longactin, (S,R)-Noscapine, L-.alpha.-Narcotine, NSC-5366, 8V32U4AOQU, Noscapine hydrochloride, Noskapin, dl-Narcotine, alpha-Gnoscopine, CHEBI:73237, Noscapine dl-form, NSC5366, AKNNEGZIBPJZJG-MSOLQXFVSA-N, L-alpha-Noscapine, 8-Methoxyhydrastin, Coscopin (VAN), Noscapine HCl, (-)-alpha-Norcotine, ( -)-alpha-Narcotine, Noscapinum [INN-Latin], Noscapina [INN-Spanish], DSSTox_CID_3385, DSSTox_RID_77007, DSSTox_GSID_23385, (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-2-benzofuran-1(3H)-one, (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one, (S)-6,7-dimethoxy-3-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one, HSDB 3372, Narcotine alkaloid, EINECS 204-899-2, NSC 96350, BRN 0099933, Narcotine, (+-)-, (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one, [S-(R*,S*)]-6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-1(3H)-Isobenzofuranone, 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)-isoquinolin-5-yl), (S-(R*,S*))-, SMR000059119, (+-)-Noscapine, (-)-.alpha.-Norcotine, (+-)-alpha-Narcotine, 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (S-(R*,S*))-, 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]-, 6035-40-1, Anarkotin, CCRIS 9304, Noscapine [USP:INN:BAN:JAN], .beta.-Narcotine, (-)-3-(2-Methyl-6,7-methylendioxy-8-methoxy-1-isochinolyl)-6,7-dimethoxyphthalid, 1-alpha-Narcotine, Noscapine (TN), (-)-noscapine, NCGC00016388-01, 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)-rel-, 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)-, 5-(6,7-Dimethoxyphthalidyl)-5,6,7,8-tetrahydro-4-methoxy-8-methyl-1,3-dioxolo(4,5-g)isoquinoline, CAS-128-62-1, L-alpha-2-Methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinaline, Narcotine (8CI), Prestwick_959, (-)-a-Narcotine, (S,R)-Nosapine, 1-.alpha.-Narcotine, (-)-|A-Narcotine, Tocris-1697, Prestwick0_000563, Prestwick1_000563, Prestwick2_000563, Prestwick3_000563, (-)-.alpha.-Narcotine, CBMicro_048259, D0Y8AW, AC1L5H7B, SCHEMBL4559, (S,R)-Noscapine, 97%, Lopac0_000840, BSPBio_000346, 4-27-00-06838 (Beilstein Handbook Reference), MLS000069475, MLS001060855, ARONIS24067, SPBio_002565, Noscapine (JP15/USP/INN), Noscapine (JP17/USP/INN), BPBio1_000382, CHEMBL364713, DTXSID4023385, BBC/205, MolPort-000-487-311, HMS1569B08, HMS2096B08, HMS2269P05, 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)-, 6,7-Dimethoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one, (S-(R*,S*))- #, Phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, Tox21_110413, BBL012344, BDBM50424716, CB3304, NSC121869, STK054401, ZINC19418974, Noscapine 1.0 mg/ml in Acetonitrile, AKOS000278036, Tox21_110413_1, API0003636, CCG-204096, CS-5115, MCULE-5334942206, NSC-121869, NCGC00023230-02, NCGC00023230-04, NCGC00023230-05, NCGC00023230-07, NCGC00023230-08, NCGC00023230-10, AC-20272, CC-33083, HY-13716, NCI60_004322, BIM-0048054.P001, H2069, C09592, D01036, A805851, C-21952, SR-01000075529-6, W-201012, 5-g)isoquinolin-5-yl)-,(s-(r*,s*))-3-dioxolo(4, 5-g]isoquinolin-5-yl)-,[s-(theta,s)]-3-dioxolo[4, BRD-K89237706-001-03-8, Noscapine, European Pharmacopoeia (EP) Reference Standard, UNII-A4C6WE7BZN component AKNNEGZIBPJZJG-MSOLQXFVSA-N, Noscapine, United States Pharmacopeia (USP) Reference Standard, WLN: T C566 DO FO KN EH & & TJ HO1 K1 J-DT56 BVO DHJ HO1 IO1, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1(3h)-isobenzofuranon, (3S)-3-[(5R)-6-methyl-4-(methyloxy)-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,7-bis(methyloxy)-2-benzofuran-1(3H)-one, (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydro-2-benzofuran-1-one, (3S)-6,7-Dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-1(3H)-isobenzofuranone, 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)-(+-)-, 1(3H)-Isobenzofuranone,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]-, 1368-39-4, 567-86-2, 8055-18-3, 8057-19-0, Phthalide,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-